DST | Outcome of Group 1 (N = 47) | Outcome of Group 2 (N = 22) | ||||
---|---|---|---|---|---|---|
 | Cure | Death | Failure | Cure | Death | Failure |
Unknown | 5 (22.7%) | 8 (61.5%) | 5 (41.7%) | 5 (26.3%) | 1 (100%) | 1 (50%) |
Sensitive | 10 (45.5%) | 3 (23.1%) | 2 (16.7%) | 11 (57.9%) | 0 | 0 |
Mono-drug resistant | 4 (18.2%) | 1 (7.7%) | 2 (16.7%) | 2 (10.5%) | 0 | 1 (50%) |
Poly-drug resistant | 2 (9.1%) | 0 | 2 (16.7%) | 0 | 0 | 0 |
MDR | 1 (4.5%) | 1 (7.7%) | 1 (8.3%) | 1 (5.3%) | 0 | 0 |